← Open Payments lookup

TAYLOR RIGGINS: Open Payments

NPI 1366224669 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,022 in 59 payments from 10 companies in 2025. Trend: 2023 $46 · 2024 $994 · 2025 $1,022

Food & beverage: $910Education: $111
CompanyPaymentsAmount
Alkermes, Inc.14$276
ABBVIE INC.14$194
Teva Pharmaceuticals USA, Inc.7$178
Otsuka America Pharmaceutical, Inc.12$143
Neurocrine BioSciences, Inc.5$94
Vanda Pharmaceuticals Inc.2$49
Janssen Pharmaceuticals, Inc2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Axsome Therapeutics, Inc.1$21
E.R. Squibb & Sons, L.L.C.1$16

Products named: ARISTADA, VRAYLAR, ABILIFY ASIMTUFII, INGREZZA, FANAPT, REXULTI, UZEDY, AUSTEDO XR.

Industry payments across MO — which companies pay providers there.